SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-136950
Filing Date
2021-11-10
Accepted
2021-11-10 16:15:40
Documents
14
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2132517d1_8k.htm   iXBRL 8-K 26661
2 EXHIBIT 99.1 tm2132517d1_ex99-1.htm EX-99.1 140332
6 GRAPHIC tm2132517d1_ex99-1img001.jpg GRAPHIC 5633
  Complete submission text file 0001104659-21-136950.txt   365179

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mxct-20211029.xsd EX-101.SCH 3186
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mxct-20211029_lab.xml EX-101.LAB 34594
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mxct-20211029_pre.xml EX-101.PRE 22711
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2132517d1_8k_htm.xml XML 3707
Mailing Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878
Business Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

IRS No.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40674 | Film No.: 211396810
SIC: 8731 Services-Commercial Physical & Biological Research